Vilket är priset för EFFECTOR Therapeutics, Inc. (EFTRW)

Priset för EFFECTOR Therapeutics, Inc. (EFTRW) är $0.0006

Vilket är marknadsvärdet för EFFECTOR Therapeutics, Inc. (EFTRW)

Marknadsvärdet för EFFECTOR Therapeutics, Inc. (EFTRW) är $2.82K

EFFECTOR Therapeutics, Inc. (EFTRW) Utestående Aktier

eFFECTOR Therapeutics, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to pioneering selective translation regulator inhibitors aimed at combating cancer. Their primary investigational drug, Tomivosertib, is an orally administered small-molecule MNK inhibitor currently undergoing Phase 2b clinical trials. This candidate is being evaluated for its efficacy in patients suffering from metastatic non-small cell lung cancer. Additionally, the company is advancing zotatifin, another small molecule engineered to block eukaryotic initiation factor 4A (eIF4E). Zotatifin is presently in Phase 1/2 clinical studies for individuals with various solid tumors. Furthermore, it's being tested in a Phase 2a open-label expansion cohort, in conjunction with fulvestrant and abemaciclib, for patients afflicted with ER-positive breast cancer. eFFECTOR Therapeutics, Inc. also holds a research collaboration and licensing pact with Pfizer Inc., focused on co-developing eIF4E inhibitors. Established in 2012, the company maintains its corporate headquarters in Solana Beach, California.

År	Utestående aktier	Ändra
Inte tillräckligt med data för de angivna datumen.

År

Utestående aktier

Ändra

Inte tillräckligt med data för de angivna datumen.

Företag	Utestående aktier	Skillnad	Land
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Argenx SE ARGX.US	62.19M	-	NL
Lonza Group AG LONN.SW	-	-	CH
UCB S.A. UCB.BR	0.00	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR

Företag

Utestående aktier

Skillnad

Land